Variation in RNA Virus Mutation Rates across Host Cells

PLoS Pathogens

Volumn 10, Issue 1, 2014, Pages

  Combe, Marine ^a   Sanjuán, Rafael ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; HAMSTER; MOLECULAR EVOLUTION; MOUSE; MUTATION; PHYSIOLOGY; TUMOR CELL LINE; VESICULOVIRUS; VIRUS REPLICATION;

ANIMALS; CELL LINE, TUMOR; CRICETINAE; EVOLUTION, MOLECULAR; MICE; MUTATION; VESICULOVIRUS; VIRUS REPLICATION;

EID: 84893777917     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003855     Document Type: Article

References (69)

1. Duffy S, Shackelton LA, Holmes EC, (2008) Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9: 267-276.
2. Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R, (2010) Viral mutation rates. J Virol 84: 9733-9748.
3. Pfeiffer JK, Kirkegaard K, (2005) Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog 1: e11.
4. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R, (2006) Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439: 344-348.
5. Vignuzzi M, Wendt E, Andino R, (2008) Engineering attenuated virus vaccines by controlling replication fidelity. Nat Med 14: 154-161.
6. Weeks SA, Lee CA, Zhao Y, Smidansky ED, August A, et al. (2012) A Polymerase mechanism-based strategy for viral attenuation and vaccine development. J Biol Chem 287: 31618-31622.
7. Anderson JP, Daifuku R, Loeb LA, (2004) Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol 58: 183-205.
8. Domingo E (2006) Quasispecies: concept and implications for virology. Springer.
9. Holmes EC, (2008) Evolutionary history and phylogeography of human viruses. Annu Rev Microbiol 62: 307-328.
10. Woolhouse M, Gaunt E, (2007) Ecological origins of novel human pathogens. Crit Rev Microbiol 33: 231-242.
11. Pepin KM, Lass S, Pulliam JR, Read AF, Lloyd-Smith JO, (2010) Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat Rev Microbiol 8: 802-813.
12. Streicker DG, Altizer SM, Velasco-Villa A, Rupprecht CE, (2012) Variable evolutionary routes to host establishment across repeated rabies virus host shifts among bats. Proc Natl Acad Sci USA 109: 19715-19720.
13. Menéndez-Arias L, (2009) Mutation rates and intrinsic fidelity of retroviral reverse transcriptases. Viruses 1: 1137-1165.
14. Pfeiffer JK, Kirkegaard K, (2003) A single mutation in poliovirus RNA-dependent RNA polymerase confers resistance to mutagenic nucleotide analogs via increased fidelity. Proc Natl Acad Sci USA 100: 7289-7294.
15. Arnold JJ, Vignuzzi M, Stone JK, Andino R, Cameron CE, (2005) Remote site control of an active site fidelity checkpoint in a viral RNA-dependent RNA polymerase. J Biol Chem 280: 25706-25716.
16. Korneeva VS, Cameron CE, (2007) Structure-function relationships of the viral RNA-dependent RNA polymerase: fidelity, replication speed, and initiation mechanism determined by a residue in the ribose-binding pocket. J Biol Chem 282: 16135-16145.
17. Roberts JD, Bebenek K, Kunkel TA, (1988) The accuracy of reverse transcriptase from HIV-1. Science 242: 1171-1173.
18. Steinhauer DA, Domingo E, Holland JJ, (1992) Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene 122: 281-288.
19. Denison MR, Graham RL, Donaldson EF, Eckerle LD, Baric RS, (2011) Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity. RNA Biol 8: 270-279.
20. Chao L, Rang CU, Wong LE, (2002) Distribution of spontaneous mutants and inferences about the replication mode of the RNA bacteriophage φ6. J Virol 76: 3276-3281.
21. Sardanyes J, Sole RV, Elena SF, (2009) Replication mode and landscape topology differentially affect RNA virus mutational load and robustness. J Virol 83: 12579-12589.
22. Pita JS, de Miranda JR, Schneider WL, Roossinck MJ, (2007) Environment determines fidelity for an RNA virus replicase. J Virol 81: 9072-9077.
23. Pita JS, Roossinck MJ, (2013) Mapping viral functional domains for genetic diversity in plants. J Virol 87: 790-797.
24. Diamond TL, Roshal M, Jamburuthugoda VK, Reynolds HM, Merriam AR, et al. (2004) Macrophage tropism of HIV-1 depends on efficient cellular dNTP utilization by reverse transcriptase. J Biol Chem 279: 51545-51553.
25. Bebenek K, Roberts JD, Kunkel TA, (1992) The effects of dNTP pool imbalances on frameshift fidelity during DNA replication. J Biol Chem 267: 3589-3596.
26. Julias JG, Pathak VK, (1998) Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate. J Virol 72: 7941-7949.
27. Holtz CM, Mansky LM, (2013) Variation of HIV-1 mutation spectra among cell types. J Virol 87: 5296-5299.
28. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, et al. (2003) DNA deamination mediates innate immunity to retroviral infection. Cell 113: 803-809.
29. Lecossier D, Bouchonnet F, Clavel F, Hance AJ, (2003) Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300: 1112.
30. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, et al. (2003) Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424: 99-103.
31. O'Hara PJ, Nichol ST, Horodyski FM, Holland JJ, (1984) Vesicular stomatitis virus defective interfering particles can contain extensive genomic sequence rearrangements and base substitutions. Cell 36: 915-924.
32. Cattaneo R, Schmid A, Eschle D, Baczko K, Ter MV, et al. (1988) Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55: 255-265.
33. Hajjar AM, Linial ML, (1995) Modification of retroviral RNA by double-stranded RNA adenosine deaminase. J Virol 69: 5878-5882.
34. Kim T, Mudry RA Jr, Rexrode CA, Pathak VK, (1996) Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol 70: 7594-7602.
35. Sharmeen L, Bass B, Sonenberg N, Weintraub H, Groudine M, (1991) Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc Natl Acad Sci USA 88: 8096-8100.
36. Seronello S, Montanez J, Presleigh K, Barlow M, Park SB, et al. (2011) Ethanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals. PLoS ONE 6: e27436.
37. Whelan SPJ (2008) Vesicular stomatitis virus. In: Mahy BWJ, van Regenmortel MHV, editors. Encyclopedia of Virology. Elsevier. pp. 291-299.
38. Letchworth GJ, Rodriguez LL, Del cbarrera J, (1999) Vesicular stomatitis. Vet J 157: 239-260.
39. Kuzmin IV, Novella IS, Dietzgen RG, Padhi A, Rupprecht CE, (2009) The rhabdoviruses: biodiversity, phylogenetics, and evolution. Infect Genet Evol 9: 541-553.
40. Comer JA, Tesh RB, Modi GB, Corn JL, Nettles VF, (1990) Vesicular stomatitis virus, New Jersey serotype: replication in and transmission by Lutzomyia shannoni (Diptera: Psychodidae). Am J Trop Med Hyg 42: 483-490.
41. Mead DG, Gray EW, Noblet R, Murphy MD, Howerth EW, et al. (2004) Biological transmission of vesicular stomatitis virus (New Jersey serotype) by Simulium vittatum (Diptera: Simuliidae) to domestic swine (Sus scrofa). J Med Entomol 41: 78-82.
42. Tesh RB, Chaniotis BN, Johnson KM, (1972) Vesicular stomatitis virus (Indiana serotype): transovarial transmission by phlebotomine sandlies. Science 175: 1477-1479.
43. Carreau A, El Hafny-Rahbi B, Matejuk A, Grillon C, Kieda C, (2011) Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia. J Cell Mol Med 15: 1239-1253.
44. Zheng Q, (1999) Progress of a half century in the study of the Luria-Delbruck distribution. Math Biosci 162: 1-32.
45. Sedivy JM, Capone JP, RajBhandary UL, Sharp PA, (1987) An inducible mammalian amber suppressor: propagation of a poliovirus mutant. Cell 50: 379-389.
46. Furió V, Moya A, Sanjuán R, (2005) The cost of replication fidelity in an RNA virus. Proc Natl Acad Sci USA 102: 10233-10237.
47. Suárez P, Valcárcel J, Ortín J, (1992) Heterogeneity of the mutation rates of influenza A viruses: isolation of mutator mutants. J Virol 66: 2491-2494.
48. Schrag SJ, Rota PA, Bellini WJ, (1999) Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol 73: 51-54.
49. de la Iglesia F, Martinez F, Hillung J, Cuevas JM, Gerrish PJ, et al. (2012) Luria-Delbruck Estimation of Turnip mosaic virus Mutation Rate in vivo. J Virol 86: 3386-3388.
50. Garcia-Villada L, Drake JW, (2012) The three faces of riboviral spontaneous mutation: spectrum, mode of genome replication, and mutation rate. PLoS Genet 8: e1002832.
51. Holland JJ, de la Torre JC, Clarke DK, Duarte E, (1991) Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J Virol 65: 2960-2967.
52. Holland JJ, de la Torre JC, Steinhauer DA, Clarke DK, Duarte EA, et al. (1989) Virus mutation frequencies can be greatly understimated by monoclonal antibody neutralization of virions. J Virol 63: 5030-5036.
53. Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr, (1975) Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure. Cancer Res 35: 2434-2439.
54. Bray G, Brent TP, (1972) Deoxyribonucleoside 5′-triphosphate pool fluctuations during the mammalian cell cycle. Biochim Biophys Acta 269: 184-191.
55. Russell SJ, Peng KW, Bell JC, (2012) Oncolytic virotherapy. Nat Biotechnol 30: 658-670.
56. Breitbach CJ, De Silva NS, Falls TJ, Aladl U, Evgin L, et al. (2011) Targeting tumor vasculature with an oncolytic virus. Mol Ther 19: 886-894.
57. Klebe RJ, Ruddle FH, (1969) Neuroblastoma: cell culture analysis of a differentiating stem cell system. J Cell Biol 43: 69A.
58. Ge P, Tsao J, Schein S, Green TJ, Luo M, et al. (2010) Cryo-EM model of the bullet-shaped vesicular stomatitis virus. Science 327: 689-693.
59. Green TJ, Zhang X, Wertz GW, Luo M, (2006) Structure of the vesicular stomatitis virus nucleoprotein-RNA complex. Science 313: 357-360.
60. Ostertag D, Hoblitzell-Ostertag TM, Perrault J, (2007) Overproduction of double-stranded RNA in vesicular stomatitis virus-infected cells activates a constitutive cell-type-specific antiviral response. J Virol 81: 503-513.
61. Novella IS, Hershey CL, Escarmis C, Domingo E, Holland JJ, (1999) Lack of evolutionary stasis during alternating replication of an arbovirus in insect and mammalian cells. J Mol Biol 287: 459-465.
62. Rodríguez LL, Fitch WM, Nichol ST, (1996) Ecological factors rather than temporal factors dominate the evolution of vesicular stomatitis virus. Proc Natl Acad Sci USA 93: 13030-13035.
63. Hanada K, Suzuki Y, Gojobori T, (2004) A large variation in the rates of synonymous substitution for RNA viruses and its relationship to a diversity of viral infection and transmission modes. Mol Biol Evol 21: 1074-1080.
64. Jenkins GM, Rambaut A, Pybus OG, Holmes EC, (2002) Rates of molecular evolution in RNA viruses: a quantitative phylogenetic analysis. J Mol Evol 54: 156-165.
65. Sanjuán R, Moya A, Elena SF, (2004) The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci USA 101: 8396-8401.
66. Whelan SP, Ball LA, Barr JN, Wertz GT, (1995) Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc Natl Acad Sci USA 92: 8388-8392.
67. Lin RJ, Liao CL, Lin E, Lin YL, (2004) Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol 78: 9285-9294.
68. Sanjuán R, (2010) Mutational fitness effects in RNA and ssDNA viruses: common patterns revealed by site-directed mutagenesis studies. Phil Trans R Soc Lond 365: 1975-1982.
69. Sanjuán R, (2012) From molecular genetics to phylodynamics: evolutionary relevance of mutation rates across viruses. PLoS Pathog 8: e1002685.